Odisha News, Odisha Latest news, Odisha Daily - OrissaPOST
  • Home
  • Trending
  • State
  • Metro
  • National
  • International
  • Business
  • Feature
  • Entertainment
  • Sports
  • More..
    • Odisha Special
    • Editorial
    • Opinion
    • Careers
    • Sci-Tech
    • Timeout
    • Horoscope
    • Today’s Pic
  • Video
  • Epaper
  • News in Odia
  • Home
  • Trending
  • State
  • Metro
  • National
  • International
  • Business
  • Feature
  • Entertainment
  • Sports
  • More..
    • Odisha Special
    • Editorial
    • Opinion
    • Careers
    • Sci-Tech
    • Timeout
    • Horoscope
    • Today’s Pic
  • Video
  • Epaper
  • News in Odia
No Result
View All Result
OrissaPOST - Odisha Latest news, English Daily -
No Result
View All Result

Gene therapy, the future medicine

Updated: July 7th, 2020, 05:00 IST
in Opinion
0
Representational image

Representational image

Share on FacebookShare on TwitterShare on WhatsAppShare on Linkedin

Bhubanananda Sahu


The US Food and Drug Administration (FDA) had taken a landmark step in the history of human discovery to approve a gene therapy drug called Luxturna for the first time, to be directly administered in patients to cure a genetic disease for lifetime. This drug was to cure the childhood blind disease called Leber’s congenital amaurosis (LCA) caused by mutation in gene retinal pigmented epithelium 65. The news was released in December 2017, and it encouraged research to develop more drugs for different genetic incurable diseases. This resembled a science fiction as seen in the 2014 movie ‘Transcendence’.

Also Read

MS Swaminathan at IARI Wheat Field (2005). (Image credit- mssrf.org)

Farmers’ Scientist

2 years ago

Taming nature

2 years ago

Since then, there is rapid development of gene therapy products with more efficacy and long sustainable cure with no toxicity, by way of modifying the carrier. The carrier is a virus and the FDA-approved gene therapy product Luxturna, that was developed in recombinant adeno-associated virus 2 serotype. This was approved only after a year of assessment of the III clinical trial. Long-term sustainability cure is noticed in newly modified AAV carrier.

This writer and his colleague published a paper in Human Gene Therapy, in May, 2019, wherein we showed that, using a different virus isotype and modified genome, long-term sustainable vision restoration is possible in preclinical trials in mice. Gene therapy is DNA-based medicine which, when injected into the body, replaces the faulty gene with healthy one in the affected tissue and it cures the disease permanently. This can be achieved via ex vivo and/or in vivo strategy using virus. There are many types of virus used for inserting genetic material into the body.

Viral gene transfer was discovered for first time by Joshua Lederberg who got Nobel Prize in physiology or medicine in 1958. Joshua demonstrated that the virus called bacteriophage can transfer the genetic material to bacteria. After many researches, a special kind of virus was found which is associated with other viruses for propagation. This special virus is called adeno-associated virus (AAV) as it is associated with adenovirus (AdV) for its replication. The AdV is found in the adenoid (nasopha-ryngeal tonsil) of humans.

The AAV was accidentally discovered as a contaminant in the culture of human AdV by two groups in 1960 in a lab at Baltimore. The AAV is a non-enveloped, single strand DNA genome either positive or negative-sensed whose genetic material is about 4680 base pairs. The wild-type AAV is nonpathogenic as it needs a helper virus such as AdV for its replication. It took quite a long time to use AAV for gene therapy. The first gene transfer to human by AAV was approved in 1989 and first therapeutic study done in 1990 to adenosine deaminase deficiency patients with severe combined immunodeficiency. The result was not great.

LCA is severe retinal dystrophy that affects the patient from childhood. It was a long quest for developing a gene therapy cure for a genetically inherited disease in the USA. It took 20 years after identification of gene for approval of gene therapy drug for LCA. The gene for LCA was first discovered in 1997. Several groups also made attempts to perform gene therapy in mice deficient with RPE65 and obtained success. After prechnical arms in dog and mice, first attempt was made by two groups in 2008. The University of London reported treatment of 3 subjects by AAV 2/2 vector containing the human RPE65 cDNA driven by human RPE65 promoter. There was no significant visual improvement in the first group and slower visual function improvement in second group. However a study provided the basis for further gene therapy. In 2012, UPENN/UFL published the gene therapy result wherein visual sensitivities of retina improved significantly in treated region with a sustained result for 3 years.

A peer-reviewed research published in The Lancet a while later changed the look of the whole gene therapy community where trial found greater efficacy and safety and clinically meaningful and statistically significant improvements in patients and their ability to navigate independently in low-to-moderate light conditions. After this, FDA approved first gene therapy drug for treatment for a genetic disease. We are now in a great time with new technology to cure diseases. Recently this technology is also used to develop vaccine for Covid-19 Boston’s Massachusetts Eye and Ear and Massachusetts General Hospital are now moving ahead to develop vaccine for coronavirus using AAV technology and planning for clinical trial later this year.

The writer is Research Specialist with UMASS Medical School, WORCESTER, MA, USA.

Tags: Bhubanananda Sahugene therapyLuxturna
ShareTweetSendShare
Suggest A Correction

Enter your email to get our daily news in your inbox.

 

OrissaPOST epaper Sunday POST OrissaPOST epaper

Click Here: Plastic Free Odisha

#MyPaperBagChallenge

Anshuman Sahoo

December 12, 2019
#MyPaperBagChallenge

Parbati Mohanty

December 12, 2019
#MyPaperBagChallenge

Mandakini Dakua

December 12, 2019
#MyPaperBagChallenge

Tapaswini Mallick

December 12, 2019
#MyPaperBagChallenge

Ramakanta Sahoo

December 12, 2019
#MyPaperBagChallenge

Subhajyoti Mohanty

December 12, 2019
#MyPaperBagChallenge

Geetanjali Patro

December 12, 2019
#MyPaperBagChallenge

Anup Mahapatra

December 12, 2019
#MyPaperBagChallenge

Sarfraz Ahmad

December 12, 2019
#MyPaperBagChallenge

Arya Ayushman

December 12, 2019
#MyPaperBagChallenge

Subhajyoti Mohanty

December 12, 2019
#MyPaperBagChallenge

Keshab Chandra Rout

December 12, 2019
#MyPaperBagChallenge

Mrutyunjaya Behera

December 12, 2019
#MyPaperBagChallenge

Rajashree Manasa Mohanty

December 12, 2019
#MyPaperBagChallenge

Sisirkumar Maharana

December 12, 2019
#MyPaperBagChallenge

Archana Parida

December 12, 2019
#MyPaperBagChallenge

Akriti Negi

December 12, 2019
#MyPaperBagChallenge

Faiza Firdous

December 12, 2019
#MyPaperBagChallenge

Akshaya Kumar Dash

December 12, 2019
#MyPaperBagChallenge

Archit Mohapatra

December 12, 2019
#MyPaperBagChallenge

Jyotshna Mayee Pattnaik

December 12, 2019
#MyPaperBagChallenge

Priyasha Pradhan

December 12, 2019
#MyPaperBagChallenge

D Rama Rao

December 12, 2019
#MyPaperBagChallenge

Aishwarya Ranjan Mohanty

December 12, 2019
?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
#MyPaperBagChallenge

Dibya Ranjan Das

December 12, 2019
#MyPaperBagChallenge

Pragyan Priyambada

December 12, 2019
#MyPaperBagChallenge

Sarmistha Nayak

December 12, 2019
#MyPaperBagChallenge

Pratyasharani Ghibela

December 12, 2019
#MyPaperBagChallenge

Adyasha Priyadarsani Sendha

December 12, 2019
#MyPaperBagChallenge

Pitabas Tripathy

December 12, 2019

Archives

Editorial

Bureaucratic Foresight

May 17, 2025

Hostilities between India and Pakistan have ceased, for the moment, but when your neighbour has a history of lobbing more...

Read more

Sound & Fury

China-US
May 14, 2025

The outcome of any war between two unequal forces could be predictable – maybe the stronger side wins and the...

Read more

Breaking Walls

Pope Leo XIV
May 13, 2025

I t is of great significance that Robert Francis Prevost, who has succeeded Pope Francis, repeated the word ‘peace’ ten...

Read more

Dangerous Liaisons

india pakistan
May 12, 2025

India and Pakistan have halted military actions for now, a day after Pakistan breached a ceasefire initially announced to the...

Read more
  • Home
  • State
  • Metro
  • National
  • International
  • Business
  • Editorial
  • Opinion
  • Sports
  • About Us
  • Advertise
  • Contact Us
  • Jobs
Developed By Ratna Technology

© 2024 All rights Reserved by OrissaPOST

  • News in Odia
  • Orissa POST Epaper
  • Video
  • Home
  • Trending
  • Metro
  • State
  • Odisha Special
  • National
  • International
  • Sports
  • Business
  • Editorial
  • Entertainment
  • Horoscope
  • Careers
  • Feature
  • Today’s Pic
  • Opinion
  • Sci-Tech
  • About Us
  • Contact Us
  • Jobs

© 2024 All rights Reserved by OrissaPOST

    • News in Odia
    • Orissa POST Epaper
    • Video
    • Home
    • Trending
    • Metro
    • State
    • Odisha Special
    • National
    • International
    • Sports
    • Business
    • Editorial
    • Entertainment
    • Horoscope
    • Careers
    • Feature
    • Today’s Pic
    • Opinion
    • Sci-Tech
    • About Us
    • Contact Us
    • Jobs

    © 2024 All rights Reserved by OrissaPOST